United States · FDA National Drug Code directory

Quflora Pediatric

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
15370-103_0ad40f28-c81d-440a-8c07-d59f667487ed
Product NDC
15370-103
Form
TABLET, CHEWABLE
Composition / generic term
VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, THIAMINE HYDROCHLORIDE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, LEVOMEFOLIC ACID, FOLIC ACID, CYANOCOBALAMIN, MAGNESIUM OXIDE, CUPRIC SULFATE, and SODIUM FLUORIDE
Labeler
CarWin Pharmaceutical Associates, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start / end (source format)
20140106
Source listing expiry
20261231

Source-listed ingredients

  • VITAMIN A ACETATE — 1200 [iU]/1
  • ASCORBIC ACID — 60 mg/1
  • CHOLECALCIFEROL — 400 [iU]/1
  • .ALPHA.-TOCOPHEROL, DL- — 15 [iU]/1
  • THIAMINE HYDROCHLORIDE — 1.2 mg/1
  • RIBOFLAVIN — 1.3 mg/1
  • NIACINAMIDE — 5 mg/1
  • PYRIDOXINE HYDROCHLORIDE — 1.5 mg/1
  • LEVOMEFOLIC ACID — 108 ug/1
  • FOLIC ACID — 100 ug/1
  • CYANOCOBALAMIN — 4 ug/1
  • MAGNESIUM OXIDE — 15 mg/1
  • CUPRIC SULFATE — 1 mg/1
  • SODIUM FLUORIDE — .25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, CHEWABLE in 1 BOTTLE (15370-103-30) · 15370-103-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →